W T Smith

Summary

Publications

  1. ncbi request reprint Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study
    W T Smith
    Summit Research Network, Portland, Ore 97209, USA
    Am J Psychiatry 155:1339-45. 1998
  2. ncbi request reprint Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression?
    Ward T Smith
    Summit Research Network, 1849 NW Kearney, Portland, OR 97209, USA
    J Affect Disord 70:251-9. 2002
  3. ncbi request reprint Gepirone extended-release: new evidence for efficacy in the treatment of major depressive disorder
    Alan D Feiger
    Feiger Health Research Center, Wheat Ridge, CO 80033, USA
    J Clin Psychiatry 64:243-9. 2003
  4. ncbi request reprint Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study
    Michael R Liebowitz
    New York State Psychiatric Institute, New York, NY, USA
    J Clin Psychiatry 64:785-92. 2003
  5. ncbi request reprint Gepirone extended-release in the treatment of adult outpatients with major depressive disorder: a double-blind, randomized, placebo-controlled, parallel-group study
    Robert J Bielski
    Summit Research Network, Inc, Okemos, Mich 48864, USA
    J Clin Psychiatry 69:571-7. 2008
  6. ncbi request reprint Pregabalin in generalized anxiety disorder: a placebo-controlled trial
    Atul C Pande
    Pfizer Global Research and Development, Ann Arbor Laboratories, MI, USA
    Am J Psychiatry 160:533-40. 2003
  7. ncbi request reprint A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder
    Richard C Shelton
    Department of Psychiatry, Vanderbilt University Medical Center, Nashville, Tenn, USA
    J Clin Psychiatry 67:1674-81. 2006

Detail Information

Publications7

  1. ncbi request reprint Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study
    W T Smith
    Summit Research Network, Portland, Ore 97209, USA
    Am J Psychiatry 155:1339-45. 1998
    ....
  2. ncbi request reprint Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression?
    Ward T Smith
    Summit Research Network, 1849 NW Kearney, Portland, OR 97209, USA
    J Affect Disord 70:251-9. 2002
    ..A new 18-week double-blind study attempted to replicate these findings to determine whether superiority would extend to 3 months and assess risks of extension...
  3. ncbi request reprint Gepirone extended-release: new evidence for efficacy in the treatment of major depressive disorder
    Alan D Feiger
    Feiger Health Research Center, Wheat Ridge, CO 80033, USA
    J Clin Psychiatry 64:243-9. 2003
    ..To assess the efficacy and tolerability of the 5-HT(1A) agonist gepirone in extended-release formulation (gepirone-ER) versus placebo in patients with major depressive disorder...
  4. ncbi request reprint Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study
    Michael R Liebowitz
    New York State Psychiatric Institute, New York, NY, USA
    J Clin Psychiatry 64:785-92. 2003
    ..The goal of the current study was to evaluate the efficacy and tolerability of sertraline for the treatment of severe generalized social anxiety disorder in adults...
  5. ncbi request reprint Gepirone extended-release in the treatment of adult outpatients with major depressive disorder: a double-blind, randomized, placebo-controlled, parallel-group study
    Robert J Bielski
    Summit Research Network, Inc, Okemos, Mich 48864, USA
    J Clin Psychiatry 69:571-7. 2008
    ..To evaluate the efficacy and tolerability of extended-release gepirone (gepirone-ER), a 5-HT(1A) agonist, versus placebo in the treatment of adult outpatients with major depressive disorder (MDD)...
  6. ncbi request reprint Pregabalin in generalized anxiety disorder: a placebo-controlled trial
    Atul C Pande
    Pfizer Global Research and Development, Ann Arbor Laboratories, MI, USA
    Am J Psychiatry 160:533-40. 2003
    ..Current drug therapies for generalized anxiety disorder have limitations. In a controlled trial, the novel agent pregabalin was studied for the treatment of patients with generalized anxiety disorder...
  7. ncbi request reprint A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder
    Richard C Shelton
    Department of Psychiatry, Vanderbilt University Medical Center, Nashville, Tenn, USA
    J Clin Psychiatry 67:1674-81. 2006
    ..The objective of the current multisite study was to compare relatively higher doses of sertraline (i.e., 150 mg/day) and venlafaxine extended release (XR) (225 mg/day) in outpatients with major depressive disorder...